Stockreport

Sumitomo Pharma shares plunge nearly 16% despite greenlight for Parkinson's treatment [MSNBC.com]

SUMITOMO CHEM UNSP/ADR  (SOMMY) 
NASDAQ:AMEX Investor Relations: sumitomo-chem.co.jp/english/ir
PDF Shares of Japanese drugmaker Sumitomo Pharma fell 15.60% Friday on what appeared to be profit-taking, a day after the governmentendorsed the company's iPS cell-based the [Read more]